Loading…
Fierce Drug Dev Forum 2019 has ended
avatar for Tara Nickerson Ph.D.

Tara Nickerson Ph.D.

MAZE THERAPEUTICS
Chief Business Officer
Dr. Tara Nickerson brings to Maze more than 20 years of experience building biotechnology businesses from startup to commercialization, serving in chief business officer and corporate board secretary roles. Known for leading company-building efforts, strategic partnering, corporate transactions and board of directors’ governance for life sciences companies, Tara has guided strategic development, partnering and corporate spinoff transactions.

Tara joins Maze from Prothena Corporation, where she served as chief business officer and was on the core team that formed Prothena as a public company via a spin-off from Elan Pharmaceuticals. There, she led early market development for new products business development, manufacturing and global facilities & IT and executed the company’s collaboration agreements with Celgene and Roche. Prior to Prothena, she held concurrent roles as vice president and head of business development at Elan Pharmaceuticals, and vice president and head of corporate development at Neotope Biosciences, a wholly-owned Elan subsidiary. Tara is currently an active member of Women in Bio and Canadian Entrepreneurs in Life Sciences.

Tara holds a Ph.D. in experimental medicine and a B.Sc. in biology from McGill University in Montreal, Canada. She also holds an MBA from the University of California at Berkeley, Walter A. Haas School of Business.

My Speakers Sessions

Monday, October 28
 

8:30am

1:00pm

 
Tuesday, October 29
 

8:45am